nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—CREB1—hematologic cancer	0.102	0.566	CbGaD
Adenosine monophosphate—Clofarabine—hematologic cancer	0.0903	0.247	CrCtD
Adenosine monophosphate—Nelarabine—hematologic cancer	0.0849	0.233	CrCtD
Adenosine monophosphate—PIM1—Mitoxantrone—hematologic cancer	0.0801	0.729	CbGbCtD
Adenosine monophosphate—Fludarabine—hematologic cancer	0.0663	0.182	CrCtD
Adenosine monophosphate—Cytarabine—hematologic cancer	0.0626	0.171	CrCtD
Adenosine monophosphate—Cladribine—hematologic cancer	0.061	0.167	CrCtD
Adenosine monophosphate—SRC—hematologic cancer	0.0411	0.229	CbGaD
Adenosine monophosphate—PDE4B—hematologic cancer	0.0367	0.205	CbGaD
Adenosine monophosphate—SRC—Dasatinib—hematologic cancer	0.0298	0.271	CbGbCtD
Adenosine monophosphate—Flavin adenine dinucleotide—Fludarabine—hematologic cancer	0.0105	0.0418	CrCrCtD
Adenosine monophosphate—Adenosine triphosphate—Nelarabine—hematologic cancer	0.00647	0.0257	CrCrCtD
Adenosine monophosphate—Ribavirin—Clofarabine—hematologic cancer	0.00637	0.0253	CrCrCtD
Adenosine monophosphate—Ribavirin—Nelarabine—hematologic cancer	0.00599	0.0238	CrCrCtD
Adenosine monophosphate—Regadenoson—Clofarabine—hematologic cancer	0.00595	0.0236	CrCrCtD
Adenosine monophosphate—S-Adenosylmethionine—Clofarabine—hematologic cancer	0.00595	0.0236	CrCrCtD
Adenosine monophosphate—Regadenoson—Nelarabine—hematologic cancer	0.00559	0.0222	CrCrCtD
Adenosine monophosphate—Clofarabine—Nelarabine—hematologic cancer	0.00559	0.0222	CrCrCtD
Adenosine monophosphate—S-Adenosylmethionine—Nelarabine—hematologic cancer	0.00559	0.0222	CrCrCtD
Adenosine monophosphate—Fludarabine—Clofarabine—hematologic cancer	0.00558	0.0222	CrCrCtD
Adenosine monophosphate—Cladribine—Pentostatin—hematologic cancer	0.0053	0.0211	CrCrCtD
Adenosine monophosphate—Vidarabine—Pentostatin—hematologic cancer	0.0053	0.0211	CrCrCtD
Adenosine monophosphate—Adenosine—Pentostatin—hematologic cancer	0.0053	0.0211	CrCrCtD
Adenosine monophosphate—Azacitidine—Pentostatin—hematologic cancer	0.0053	0.0211	CrCrCtD
Adenosine monophosphate—Nelarabine—Clofarabine—hematologic cancer	0.00526	0.0209	CrCrCtD
Adenosine monophosphate—Fludarabine—Nelarabine—hematologic cancer	0.00524	0.0209	CrCrCtD
Adenosine monophosphate—Adenosine triphosphate—Fludarabine—hematologic cancer	0.00505	0.0201	CrCrCtD
Adenosine monophosphate—Cytarabine—Clofarabine—hematologic cancer	0.00497	0.0198	CrCrCtD
Adenosine monophosphate—Adenosine—Clofarabine—hematologic cancer	0.00472	0.0188	CrCrCtD
Adenosine monophosphate—Vidarabine—Clofarabine—hematologic cancer	0.00472	0.0188	CrCrCtD
Adenosine monophosphate—Cladribine—Clofarabine—hematologic cancer	0.00472	0.0188	CrCrCtD
Adenosine monophosphate—Azacitidine—Clofarabine—hematologic cancer	0.00472	0.0188	CrCrCtD
Adenosine monophosphate—Ribavirin—Fludarabine—hematologic cancer	0.00468	0.0186	CrCrCtD
Adenosine monophosphate—Cytarabine—Nelarabine—hematologic cancer	0.00468	0.0186	CrCrCtD
Adenosine monophosphate—Adenosine—Nelarabine—hematologic cancer	0.00444	0.0177	CrCrCtD
Adenosine monophosphate—Azacitidine—Nelarabine—hematologic cancer	0.00444	0.0177	CrCrCtD
Adenosine monophosphate—Vidarabine—Nelarabine—hematologic cancer	0.00444	0.0177	CrCrCtD
Adenosine monophosphate—Cladribine—Nelarabine—hematologic cancer	0.00444	0.0177	CrCrCtD
Adenosine monophosphate—Ribavirin—Cytarabine—hematologic cancer	0.00442	0.0176	CrCrCtD
Adenosine monophosphate—S-Adenosylmethionine—Fludarabine—hematologic cancer	0.00436	0.0174	CrCrCtD
Adenosine monophosphate—Regadenoson—Fludarabine—hematologic cancer	0.00436	0.0174	CrCrCtD
Adenosine monophosphate—Clofarabine—Fludarabine—hematologic cancer	0.00436	0.0174	CrCrCtD
Adenosine monophosphate—Clofarabine—Cytarabine—hematologic cancer	0.00412	0.0164	CrCrCtD
Adenosine monophosphate—S-Adenosylmethionine—Cytarabine—hematologic cancer	0.00412	0.0164	CrCrCtD
Adenosine monophosphate—Regadenoson—Cytarabine—hematologic cancer	0.00412	0.0164	CrCrCtD
Adenosine monophosphate—Regadenoson—Cladribine—hematologic cancer	0.00402	0.016	CrCrCtD
Adenosine monophosphate—Clofarabine—Cladribine—hematologic cancer	0.00402	0.016	CrCrCtD
Adenosine monophosphate—Fludarabine—Cytarabine—hematologic cancer	0.00387	0.0154	CrCrCtD
Adenosine monophosphate—Nelarabine—Fludarabine—hematologic cancer	0.00386	0.0153	CrCrCtD
Adenosine monophosphate—Fludarabine—Cladribine—hematologic cancer	0.00377	0.015	CrCrCtD
Adenosine monophosphate—Cytarabine—Fludarabine—hematologic cancer	0.00365	0.0145	CrCrCtD
Adenosine monophosphate—Nelarabine—Cytarabine—hematologic cancer	0.00364	0.0145	CrCrCtD
Adenosine monophosphate—Nelarabine—Cladribine—hematologic cancer	0.00355	0.0141	CrCrCtD
Adenosine monophosphate—Vidarabine—Fludarabine—hematologic cancer	0.00347	0.0138	CrCrCtD
Adenosine monophosphate—Cladribine—Fludarabine—hematologic cancer	0.00347	0.0138	CrCrCtD
Adenosine monophosphate—Adenosine—Fludarabine—hematologic cancer	0.00347	0.0138	CrCrCtD
Adenosine monophosphate—Azacitidine—Fludarabine—hematologic cancer	0.00347	0.0138	CrCrCtD
Adenosine monophosphate—Cytarabine—Gemcitabine—hematologic cancer	0.00345	0.0137	CrCrCtD
Adenosine monophosphate—Azacitidine—Gemcitabine—hematologic cancer	0.00327	0.013	CrCrCtD
Adenosine monophosphate—Azacitidine—Cytarabine—hematologic cancer	0.00327	0.013	CrCrCtD
Adenosine monophosphate—Vidarabine—Cytarabine—hematologic cancer	0.00327	0.013	CrCrCtD
Adenosine monophosphate—Adenosine—Cytarabine—hematologic cancer	0.00327	0.013	CrCrCtD
Adenosine monophosphate—Vidarabine—Cladribine—hematologic cancer	0.00319	0.0127	CrCrCtD
Adenosine monophosphate—Adenosine—Cladribine—hematologic cancer	0.00319	0.0127	CrCrCtD
Adenosine monophosphate—Azacitidine—Cladribine—hematologic cancer	0.00319	0.0127	CrCrCtD
Adenosine monophosphate—FBP1—hematopoietic system—hematologic cancer	0.000697	0.0237	CbGeAlD
Adenosine monophosphate—AMPD1—lung—hematologic cancer	0.000553	0.0188	CbGeAlD
Adenosine monophosphate—HINT1—hematopoietic system—hematologic cancer	0.000547	0.0186	CbGeAlD
Adenosine monophosphate—PRKAB2—blood—hematologic cancer	0.000478	0.0162	CbGeAlD
Adenosine monophosphate—PRKAB1—hematopoietic system—hematologic cancer	0.000468	0.0159	CbGeAlD
Adenosine monophosphate—FBP1—blood—hematologic cancer	0.000462	0.0157	CbGeAlD
Adenosine monophosphate—PYGL—blood—hematologic cancer	0.000457	0.0155	CbGeAlD
Adenosine monophosphate—FBP1—bone marrow—hematologic cancer	0.000447	0.0152	CbGeAlD
Adenosine monophosphate—PYGL—bone marrow—hematologic cancer	0.000442	0.015	CbGeAlD
Adenosine monophosphate—PIM1—hematopoietic system—hematologic cancer	0.000441	0.015	CbGeAlD
Adenosine monophosphate—ACSS2—hematopoietic system—hematologic cancer	0.000435	0.0148	CbGeAlD
Adenosine monophosphate—APRT—hematopoietic system—hematologic cancer	0.000435	0.0148	CbGeAlD
Adenosine monophosphate—ACSL1—hematopoietic system—hematologic cancer	0.000433	0.0147	CbGeAlD
Adenosine monophosphate—PRKAB2—lung—hematologic cancer	0.000419	0.0142	CbGeAlD
Adenosine monophosphate—HINT1—gonad—hematologic cancer	0.000416	0.0141	CbGeAlD
Adenosine monophosphate—PRKAA1—hematopoietic system—hematologic cancer	0.000409	0.0139	CbGeAlD
Adenosine monophosphate—CREB1—hematopoietic system—hematologic cancer	0.000409	0.0139	CbGeAlD
Adenosine monophosphate—FBP1—lung—hematologic cancer	0.000405	0.0137	CbGeAlD
Adenosine monophosphate—PYGL—lung—hematologic cancer	0.000401	0.0136	CbGeAlD
Adenosine monophosphate—PRKAB2—testis—hematologic cancer	0.000395	0.0134	CbGeAlD
Adenosine monophosphate—FBP1—testis—hematologic cancer	0.000382	0.013	CbGeAlD
Adenosine monophosphate—PYGL—testis—hematologic cancer	0.000378	0.0128	CbGeAlD
Adenosine monophosphate—AMPD1—lymph node—hematologic cancer	0.000378	0.0128	CbGeAlD
Adenosine monophosphate—ADCY1—testis—hematologic cancer	0.00037	0.0126	CbGeAlD
Adenosine monophosphate—HINT1—blood—hematologic cancer	0.000362	0.0123	CbGeAlD
Adenosine monophosphate—PRKAB1—gonad—hematologic cancer	0.000356	0.0121	CbGeAlD
Adenosine monophosphate—HINT1—bone marrow—hematologic cancer	0.00035	0.0119	CbGeAlD
Adenosine monophosphate—ACSS1—gonad—hematologic cancer	0.000345	0.0117	CbGeAlD
Adenosine monophosphate—APRT—gonad—hematologic cancer	0.000331	0.0112	CbGeAlD
Adenosine monophosphate—ACSS2—gonad—hematologic cancer	0.000331	0.0112	CbGeAlD
Adenosine monophosphate—ACSL1—gonad—hematologic cancer	0.000329	0.0112	CbGeAlD
Adenosine monophosphate—HINT1—lung—hematologic cancer	0.000317	0.0108	CbGeAlD
Adenosine monophosphate—PRKAA1—gonad—hematologic cancer	0.000311	0.0106	CbGeAlD
Adenosine monophosphate—CREB1—gonad—hematologic cancer	0.000311	0.0106	CbGeAlD
Adenosine monophosphate—PRKAB1—blood—hematologic cancer	0.00031	0.0105	CbGeAlD
Adenosine monophosphate—ACSS1—blood—hematologic cancer	0.000301	0.0102	CbGeAlD
Adenosine monophosphate—PRKAB1—bone marrow—hematologic cancer	0.0003	0.0102	CbGeAlD
Adenosine monophosphate—HINT1—testis—hematologic cancer	0.000299	0.0102	CbGeAlD
Adenosine monophosphate—PIM1—blood—hematologic cancer	0.000292	0.00993	CbGeAlD
Adenosine monophosphate—ACSS1—bone marrow—hematologic cancer	0.000291	0.00989	CbGeAlD
Adenosine monophosphate—ACSS2—blood—hematologic cancer	0.000288	0.0098	CbGeAlD
Adenosine monophosphate—APRT—blood—hematologic cancer	0.000288	0.0098	CbGeAlD
Adenosine monophosphate—SRC—hematopoietic system—hematologic cancer	0.000288	0.00979	CbGeAlD
Adenosine monophosphate—ACSL1—blood—hematologic cancer	0.000287	0.00973	CbGeAlD
Adenosine monophosphate—PRKAB2—lymph node—hematologic cancer	0.000286	0.00973	CbGeAlD
Adenosine monophosphate—ADK—hematopoietic system—hematologic cancer	0.000284	0.00966	CbGeAlD
Adenosine monophosphate—PIM1—bone marrow—hematologic cancer	0.000283	0.00961	CbGeAlD
Adenosine monophosphate—ACSS2—bone marrow—hematologic cancer	0.000279	0.00948	CbGeAlD
Adenosine monophosphate—APRT—bone marrow—hematologic cancer	0.000279	0.00948	CbGeAlD
Adenosine monophosphate—ACSL1—bone marrow—hematologic cancer	0.000277	0.00942	CbGeAlD
Adenosine monophosphate—FBP1—lymph node—hematologic cancer	0.000277	0.0094	CbGeAlD
Adenosine monophosphate—PYGL—lymph node—hematologic cancer	0.000274	0.0093	CbGeAlD
Adenosine monophosphate—PRKAB1—lung—hematologic cancer	0.000272	0.00924	CbGeAlD
Adenosine monophosphate—PRKAA1—blood—hematologic cancer	0.000271	0.00921	CbGeAlD
Adenosine monophosphate—CREB1—blood—hematologic cancer	0.000271	0.00921	CbGeAlD
Adenosine monophosphate—ADCY1—lymph node—hematologic cancer	0.000268	0.00911	CbGeAlD
Adenosine monophosphate—ACSS1—lung—hematologic cancer	0.000264	0.00896	CbGeAlD
Adenosine monophosphate—PRKAA1—bone marrow—hematologic cancer	0.000262	0.00891	CbGeAlD
Adenosine monophosphate—CREB1—bone marrow—hematologic cancer	0.000262	0.00891	CbGeAlD
Adenosine monophosphate—PRKAB1—testis—hematologic cancer	0.000257	0.00872	CbGeAlD
Adenosine monophosphate—PIM1—lung—hematologic cancer	0.000256	0.0087	CbGeAlD
Adenosine monophosphate—APRT—lung—hematologic cancer	0.000253	0.00859	CbGeAlD
Adenosine monophosphate—ACSS2—lung—hematologic cancer	0.000253	0.00859	CbGeAlD
Adenosine monophosphate—ACSL1—lung—hematologic cancer	0.000251	0.00853	CbGeAlD
Adenosine monophosphate—ACSS1—testis—hematologic cancer	0.000249	0.00845	CbGeAlD
Adenosine monophosphate—PIM1—testis—hematologic cancer	0.000242	0.00821	CbGeAlD
Adenosine monophosphate—APRT—testis—hematologic cancer	0.000239	0.0081	CbGeAlD
Adenosine monophosphate—ACSS2—testis—hematologic cancer	0.000239	0.0081	CbGeAlD
Adenosine monophosphate—PRKAA1—lung—hematologic cancer	0.000238	0.00807	CbGeAlD
Adenosine monophosphate—CREB1—lung—hematologic cancer	0.000238	0.00807	CbGeAlD
Adenosine monophosphate—ACSL1—testis—hematologic cancer	0.000237	0.00805	CbGeAlD
Adenosine monophosphate—Azacitidine—DNMT3A—hematologic cancer	0.000224	0.128	CrCbGaD
Adenosine monophosphate—PRKAA1—testis—hematologic cancer	0.000224	0.00762	CbGeAlD
Adenosine monophosphate—CREB1—testis—hematologic cancer	0.000224	0.00762	CbGeAlD
Adenosine monophosphate—PDE4D—lung—hematologic cancer	0.000223	0.00756	CbGeAlD
Adenosine monophosphate—SRC—gonad—hematologic cancer	0.000219	0.00745	CbGeAlD
Adenosine monophosphate—HINT1—lymph node—hematologic cancer	0.000217	0.00737	CbGeAlD
Adenosine monophosphate—ADK—gonad—hematologic cancer	0.000216	0.00734	CbGeAlD
Adenosine monophosphate—PDE4D—testis—hematologic cancer	0.00021	0.00713	CbGeAlD
Adenosine monophosphate—PDE4B—hematopoietic system—hematologic cancer	0.000202	0.00687	CbGeAlD
Adenosine monophosphate—Azacitidine—CDA—hematologic cancer	0.0002	0.115	CrCbGaD
Adenosine monophosphate—SRC—blood—hematologic cancer	0.000191	0.00649	CbGeAlD
Adenosine monophosphate—ADK—blood—hematologic cancer	0.000188	0.0064	CbGeAlD
Adenosine monophosphate—PRKAB1—lymph node—hematologic cancer	0.000186	0.00632	CbGeAlD
Adenosine monophosphate—ADK—bone marrow—hematologic cancer	0.000182	0.00619	CbGeAlD
Adenosine monophosphate—ACSS1—lymph node—hematologic cancer	0.00018	0.00613	CbGeAlD
Adenosine monophosphate—PIM1—lymph node—hematologic cancer	0.000175	0.00595	CbGeAlD
Adenosine monophosphate—ACSS2—lymph node—hematologic cancer	0.000173	0.00587	CbGeAlD
Adenosine monophosphate—APRT—lymph node—hematologic cancer	0.000173	0.00587	CbGeAlD
Adenosine monophosphate—ACSL1—lymph node—hematologic cancer	0.000172	0.00583	CbGeAlD
Adenosine monophosphate—SRC—lung—hematologic cancer	0.000168	0.00569	CbGeAlD
Adenosine monophosphate—Nelarabine—DCK—hematologic cancer	0.000166	0.0948	CrCbGaD
Adenosine monophosphate—ADK—lung—hematologic cancer	0.000165	0.00561	CbGeAlD
Adenosine monophosphate—CREB1—lymph node—hematologic cancer	0.000163	0.00552	CbGeAlD
Adenosine monophosphate—PRKAA1—lymph node—hematologic cancer	0.000163	0.00552	CbGeAlD
Adenosine monophosphate—Clofarabine—DCK—hematologic cancer	0.000161	0.0922	CrCbGaD
Adenosine monophosphate—SRC—testis—hematologic cancer	0.000158	0.00537	CbGeAlD
Adenosine monophosphate—Fludarabine—DCK—hematologic cancer	0.000156	0.0893	CrCbGaD
Adenosine monophosphate—ADK—testis—hematologic cancer	0.000156	0.00529	CbGeAlD
Adenosine monophosphate—PDE4B—gonad—hematologic cancer	0.000154	0.00522	CbGeAlD
Adenosine monophosphate—PDE4D—lymph node—hematologic cancer	0.000152	0.00517	CbGeAlD
Adenosine monophosphate—PYGL—Azacitidine—Pentostatin—hematologic cancer	0.000151	0.163	CbGdCrCtD
Adenosine monophosphate—CREB1—Gemcitabine—Cytarabine—hematologic cancer	0.000136	0.147	CbGdCrCtD
Adenosine monophosphate—PYGL—Azacitidine—Clofarabine—hematologic cancer	0.000134	0.146	CbGdCrCtD
Adenosine monophosphate—PDE4B—blood—hematologic cancer	0.000134	0.00455	CbGeAlD
Adenosine monophosphate—PDE4B—bone marrow—hematologic cancer	0.00013	0.0044	CbGeAlD
Adenosine monophosphate—PYGL—Azacitidine—Nelarabine—hematologic cancer	0.000126	0.137	CbGdCrCtD
Adenosine monophosphate—Adenosine triphosphate—ASNS—hematologic cancer	0.000118	0.0675	CrCbGaD
Adenosine monophosphate—PDE4B—lung—hematologic cancer	0.000117	0.00399	CbGeAlD
Adenosine monophosphate—SRC—lymph node—hematologic cancer	0.000115	0.00389	CbGeAlD
Adenosine monophosphate—Cytarabine—CDA—hematologic cancer	0.000114	0.0654	CrCbGaD
Adenosine monophosphate—ADK—lymph node—hematologic cancer	0.000113	0.00384	CbGeAlD
Adenosine monophosphate—PDE4B—testis—hematologic cancer	0.000111	0.00376	CbGeAlD
Adenosine monophosphate—Cytarabine—DCK—hematologic cancer	0.000101	0.0576	CrCbGaD
Adenosine monophosphate—PYGL—Azacitidine—Fludarabine—hematologic cancer	9.87e-05	0.107	CbGdCrCtD
Adenosine monophosphate—PYGL—Azacitidine—Gemcitabine—hematologic cancer	9.32e-05	0.101	CbGdCrCtD
Adenosine monophosphate—PYGL—Azacitidine—Cytarabine—hematologic cancer	9.32e-05	0.101	CbGdCrCtD
Adenosine monophosphate—Cladribine—DCK—hematologic cancer	9.25e-05	0.053	CrCbGaD
Adenosine monophosphate—PYGL—Azacitidine—Cladribine—hematologic cancer	9.08e-05	0.0984	CbGdCrCtD
Adenosine monophosphate—Adenosine triphosphate—ABL2—hematologic cancer	8.94e-05	0.0512	CrCbGaD
Adenosine monophosphate—PDE4B—lymph node—hematologic cancer	8.03e-05	0.00273	CbGeAlD
Adenosine monophosphate—Flavin adenine dinucleotide—NQO1—hematologic cancer	6.19e-05	0.0355	CrCbGaD
Adenosine monophosphate—Adenosine triphosphate—ALK—hematologic cancer	5.41e-05	0.031	CrCbGaD
Adenosine monophosphate—Adenosine triphosphate—AKT1—hematologic cancer	4.23e-05	0.0242	CrCbGaD
Adenosine monophosphate—Adenosine triphosphate—ABL1—hematologic cancer	3.99e-05	0.0228	CrCbGaD
Adenosine monophosphate—Clofarabine—ABCG2—hematologic cancer	3.63e-05	0.0208	CrCbGaD
Adenosine monophosphate—Cytarabine—SLC22A1—hematologic cancer	3.24e-05	0.0186	CrCbGaD
Adenosine monophosphate—Cladribine—SLC22A1—hematologic cancer	2.99e-05	0.0171	CrCbGaD
Adenosine monophosphate—Cladribine—ABCG2—hematologic cancer	2.09e-05	0.0119	CrCbGaD
Adenosine monophosphate—Adenosine triphosphate—ABCB1—hematologic cancer	7.38e-06	0.00423	CrCbGaD
Adenosine monophosphate—SRC—Disease—BAD—hematologic cancer	3.9e-07	6.28e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CREB1—hematologic cancer	3.9e-07	6.27e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—KRAS—hematologic cancer	3.89e-07	6.26e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MAPK3—hematologic cancer	3.88e-07	6.25e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—KITLG—hematologic cancer	3.88e-07	6.24e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL6—hematologic cancer	3.88e-07	6.24e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—STAT3—hematologic cancer	3.87e-07	6.24e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—NRAS—hematologic cancer	3.87e-07	6.22e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NOTCH1—hematologic cancer	3.86e-07	6.22e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—EP300—hematologic cancer	3.83e-07	6.16e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—CDKN1A—hematologic cancer	3.82e-07	6.16e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—STAT3—hematologic cancer	3.82e-07	6.15e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PTEN—hematologic cancer	3.82e-07	6.14e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CASP8—hematologic cancer	3.81e-07	6.14e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—NRAS—hematologic cancer	3.81e-07	6.14e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—FGF2—hematologic cancer	3.8e-07	6.12e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6R—hematologic cancer	3.8e-07	6.12e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CREBBP—hematologic cancer	3.79e-07	6.11e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—STAT5A—hematologic cancer	3.79e-07	6.1e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD80—hematologic cancer	3.79e-07	6.1e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—KIT—hematologic cancer	3.78e-07	6.08e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—MYC—hematologic cancer	3.77e-07	6.08e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TGFB1—hematologic cancer	3.77e-07	6.06e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CDKN2B—hematologic cancer	3.76e-07	6.05e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3R1—hematologic cancer	3.75e-07	6.04e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL6—hematologic cancer	3.74e-07	6.03e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—HRAS—hematologic cancer	3.74e-07	6.02e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MAPK8—hematologic cancer	3.73e-07	6.01e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—AKT1—hematologic cancer	3.72e-07	5.99e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—SRC—hematologic cancer	3.72e-07	5.99e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PTPN11—hematologic cancer	3.71e-07	5.98e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MAPK3—hematologic cancer	3.7e-07	5.96e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MAPK3—hematologic cancer	3.65e-07	5.88e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—PIK3CA—hematologic cancer	3.65e-07	5.87e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—JAK2—hematologic cancer	3.64e-07	5.87e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—EP300—hematologic cancer	3.64e-07	5.86e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CD86—hematologic cancer	3.63e-07	5.85e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—VEGFA—hematologic cancer	3.62e-07	5.83e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAP2K1—hematologic cancer	3.62e-07	5.83e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—MYC—hematologic cancer	3.6e-07	5.8e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CD—hematologic cancer	3.6e-07	5.79e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CREB1—hematologic cancer	3.6e-07	5.79e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TGFB1—hematologic cancer	3.59e-07	5.78e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—STAT3—hematologic cancer	3.59e-07	5.78e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—HES1—hematologic cancer	3.58e-07	5.77e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—NRAS—hematologic cancer	3.58e-07	5.76e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IL6—hematologic cancer	3.58e-07	5.76e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—AKT1—hematologic cancer	3.58e-07	5.76e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—KRAS—hematologic cancer	3.57e-07	5.75e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—PIK3CA—hematologic cancer	3.57e-07	5.75e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NCOR1—hematologic cancer	3.56e-07	5.74e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MDM2—hematologic cancer	3.56e-07	5.73e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—KRAS—hematologic cancer	3.55e-07	5.72e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—BRAF—hematologic cancer	3.55e-07	5.72e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MYC—hematologic cancer	3.55e-07	5.72e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—TGFB1—hematologic cancer	3.54e-07	5.7e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—SRC—hematologic cancer	3.54e-07	5.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—TP53—hematologic cancer	3.53e-07	5.68e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CSF2—hematologic cancer	3.52e-07	5.67e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FGF1—hematologic cancer	3.52e-07	5.67e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6R—hematologic cancer	3.51e-07	5.65e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CREBBP—hematologic cancer	3.5e-07	5.64e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—KRAS—hematologic cancer	3.49e-07	5.62e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FOXO1—hematologic cancer	3.47e-07	5.59e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PDGFRB—hematologic cancer	3.47e-07	5.58e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3CB—hematologic cancer	3.46e-07	5.57e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MTOR—hematologic cancer	3.46e-07	5.57e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—AKT1—hematologic cancer	3.45e-07	5.56e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—VEGFA—hematologic cancer	3.45e-07	5.55e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—FGF2—hematologic cancer	3.44e-07	5.55e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—HRAS—hematologic cancer	3.44e-07	5.54e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—KRAS—hematologic cancer	3.43e-07	5.52e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MAPK3—hematologic cancer	3.43e-07	5.52e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—STAT3—hematologic cancer	3.41e-07	5.5e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PDGFRA—hematologic cancer	3.41e-07	5.5e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—NRAS—hematologic cancer	3.4e-07	5.48e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PRKCG—hematologic cancer	3.4e-07	5.48e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—JAK1—hematologic cancer	3.4e-07	5.48e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3R1—hematologic cancer	3.4e-07	5.47e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—PIK3CA—hematologic cancer	3.38e-07	5.45e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—HRAS—hematologic cancer	3.37e-07	5.43e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MAP2K1—hematologic cancer	3.34e-07	5.38e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—MYC—hematologic cancer	3.33e-07	5.37e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—KRAS—hematologic cancer	3.33e-07	5.36e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TGFB1—hematologic cancer	3.33e-07	5.36e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CD—hematologic cancer	3.32e-07	5.35e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—HRAS—hematologic cancer	3.3e-07	5.32e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—JAK2—hematologic cancer	3.3e-07	5.32e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—AKT1—hematologic cancer	3.3e-07	5.32e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—IL6—hematologic cancer	3.29e-07	5.3e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—PIK3CA—hematologic cancer	3.28e-07	5.29e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—KRAS—hematologic cancer	3.28e-07	5.28e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—BCL2—hematologic cancer	3.27e-07	5.27e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—PIK3CA—hematologic cancer	3.26e-07	5.26e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MAPK3—hematologic cancer	3.26e-07	5.25e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CDKN1B—hematologic cancer	3.25e-07	5.23e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IFNG—hematologic cancer	3.24e-07	5.22e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MDM2—hematologic cancer	3.22e-07	5.19e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—PIK3CA—hematologic cancer	3.2e-07	5.16e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CASP3—hematologic cancer	3.18e-07	5.13e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—FGF2—hematologic cancer	3.18e-07	5.12e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL2—hematologic cancer	3.18e-07	5.12e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2RA—hematologic cancer	3.18e-07	5.11e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—MYC—hematologic cancer	3.17e-07	5.11e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TGFB1—hematologic cancer	3.16e-07	5.09e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL6—hematologic cancer	3.16e-07	5.09e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—PIK3CA—hematologic cancer	3.15e-07	5.08e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TERT—hematologic cancer	3.14e-07	5.06e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3R1—hematologic cancer	3.14e-07	5.05e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MTOR—hematologic cancer	3.14e-07	5.05e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CB—hematologic cancer	3.14e-07	5.05e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CD4—hematologic cancer	3.13e-07	5.04e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—TP53—hematologic cancer	3.1e-07	4.99e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CCND1—hematologic cancer	3.1e-07	4.99e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—JUN—hematologic cancer	3.09e-07	4.98e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—KRAS—hematologic cancer	3.08e-07	4.96e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PDGFB—hematologic cancer	3.07e-07	4.94e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—PIK3CA—hematologic cancer	3.06e-07	4.92e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—JAK2—hematologic cancer	3.05e-07	4.91e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—HRAS—hematologic cancer	3.04e-07	4.89e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—AKT1—hematologic cancer	3.04e-07	4.89e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—HRAS—hematologic cancer	3.02e-07	4.86e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—PIK3CA—hematologic cancer	3.01e-07	4.85e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—CDKN1A—hematologic cancer	3e-07	4.83e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TSC2—hematologic cancer	3e-07	4.82e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PTEN—hematologic cancer	2.99e-07	4.82e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—AKT1—hematologic cancer	2.98e-07	4.8e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MDM2—hematologic cancer	2.98e-07	4.79e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—HRAS—hematologic cancer	2.96e-07	4.77e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—TP53—hematologic cancer	2.96e-07	4.76e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDKN1B—hematologic cancer	2.94e-07	4.74e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—KRAS—hematologic cancer	2.93e-07	4.72e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MAPK8—hematologic cancer	2.93e-07	4.71e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—AKT1—hematologic cancer	2.92e-07	4.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—HRAS—hematologic cancer	2.92e-07	4.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IL6—hematologic cancer	2.91e-07	4.68e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CB—hematologic cancer	2.9e-07	4.66e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MTOR—hematologic cancer	2.9e-07	4.66e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL1B—hematologic cancer	2.89e-07	4.66e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CD4—hematologic cancer	2.89e-07	4.65e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL6—hematologic cancer	2.89e-07	4.65e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FGFR3—hematologic cancer	2.88e-07	4.64e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL2—hematologic cancer	2.88e-07	4.64e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK14—hematologic cancer	2.85e-07	4.59e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—EP300—hematologic cancer	2.85e-07	4.59e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL6—hematologic cancer	2.84e-07	4.57e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—PIK3CA—hematologic cancer	2.83e-07	4.56e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—HRAS—hematologic cancer	2.83e-07	4.55e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—JUN—hematologic cancer	2.8e-07	4.51e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ESR1—hematologic cancer	2.8e-07	4.51e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—HRAS—hematologic cancer	2.79e-07	4.49e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—SRC—hematologic cancer	2.77e-07	4.47e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FN1—hematologic cancer	2.77e-07	4.45e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—AKT1—hematologic cancer	2.77e-07	4.45e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—TP53—hematologic cancer	2.74e-07	4.41e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—BAD—hematologic cancer	2.73e-07	4.4e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NFKBIA—hematologic cancer	2.73e-07	4.4e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CDKN1B—hematologic cancer	2.72e-07	4.38e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CDKN1A—hematologic cancer	2.72e-07	4.37e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PTEN—hematologic cancer	2.71e-07	4.36e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL6—hematologic cancer	2.71e-07	4.36e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NOTCH1—hematologic cancer	2.71e-07	4.36e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—VEGFA—hematologic cancer	2.7e-07	4.35e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PIK3CA—hematologic cancer	2.69e-07	4.33e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—AKT1—hematologic cancer	2.68e-07	4.32e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—STAT3—hematologic cancer	2.68e-07	4.31e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NRAS—hematologic cancer	2.67e-07	4.3e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IL6—hematologic cancer	2.67e-07	4.3e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—AKT1—hematologic cancer	2.67e-07	4.29e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAPK8—hematologic cancer	2.65e-07	4.27e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CD80—hematologic cancer	2.65e-07	4.27e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—KIT—hematologic cancer	2.65e-07	4.26e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CG—hematologic cancer	2.65e-07	4.26e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—HRAS—hematologic cancer	2.62e-07	4.22e-06	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—AKT1—hematologic cancer	2.62e-07	4.21e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—TP53—hematologic cancer	2.6e-07	4.19e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PTPN11—hematologic cancer	2.6e-07	4.19e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—EP300—hematologic cancer	2.58e-07	4.16e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—AKT1—hematologic cancer	2.57e-07	4.15e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MAPK3—hematologic cancer	2.56e-07	4.12e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CREB1—hematologic cancer	2.52e-07	4.06e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—CDKN1A—hematologic cancer	2.51e-07	4.04e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL6—hematologic cancer	2.51e-07	4.04e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PTEN—hematologic cancer	2.5e-07	4.03e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—AKT1—hematologic cancer	2.5e-07	4.02e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—HRAS—hematologic cancer	2.49e-07	4.01e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—BRAF—hematologic cancer	2.49e-07	4.01e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—MYC—hematologic cancer	2.49e-07	4e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TGFB1—hematologic cancer	2.48e-07	3.99e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCL2—hematologic cancer	2.46e-07	3.97e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—AKT1—hematologic cancer	2.46e-07	3.96e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6R—hematologic cancer	2.46e-07	3.96e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CREBBP—hematologic cancer	2.45e-07	3.95e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—STAT3—hematologic cancer	2.42e-07	3.9e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—NRAS—hematologic cancer	2.42e-07	3.89e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—EP300—hematologic cancer	2.39e-07	3.84e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL6—hematologic cancer	2.38e-07	3.84e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAP2K1—hematologic cancer	2.34e-07	3.77e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CD—hematologic cancer	2.33e-07	3.75e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—MAPK3—hematologic cancer	2.32e-07	3.73e-06	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—AKT1—hematologic cancer	2.31e-07	3.72e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—KRAS—hematologic cancer	2.3e-07	3.7e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—STAT3—hematologic cancer	2.24e-07	3.6e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NRAS—hematologic cancer	2.23e-07	3.59e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FGF2—hematologic cancer	2.23e-07	3.59e-06	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—AKT1—hematologic cancer	2.2e-07	3.54e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3R1—hematologic cancer	2.2e-07	3.54e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MAPK3—hematologic cancer	2.14e-07	3.44e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—JAK2—hematologic cancer	2.13e-07	3.44e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PIK3CA—hematologic cancer	2.11e-07	3.4e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MDM2—hematologic cancer	2.08e-07	3.36e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—KRAS—hematologic cancer	2.08e-07	3.35e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MYC—hematologic cancer	2.08e-07	3.35e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TGFB1—hematologic cancer	2.07e-07	3.34e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TP53—hematologic cancer	2.04e-07	3.29e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CB—hematologic cancer	2.03e-07	3.26e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MTOR—hematologic cancer	2.03e-07	3.26e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—HRAS—hematologic cancer	1.95e-07	3.14e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—KRAS—hematologic cancer	1.92e-07	3.09e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PIK3CA—hematologic cancer	1.91e-07	3.08e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CDKN1B—hematologic cancer	1.9e-07	3.06e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL6—hematologic cancer	1.87e-07	3.01e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CASP3—hematologic cancer	1.86e-07	3e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL2—hematologic cancer	1.86e-07	3e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CCND1—hematologic cancer	1.82e-07	2.92e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—JUN—hematologic cancer	1.81e-07	2.92e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—HRAS—hematologic cancer	1.77e-07	2.85e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PIK3CA—hematologic cancer	1.77e-07	2.84e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—CDKN1A—hematologic cancer	1.76e-07	2.83e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PTEN—hematologic cancer	1.75e-07	2.82e-06	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—AKT1—hematologic cancer	1.72e-07	2.78e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK8—hematologic cancer	1.71e-07	2.76e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6—hematologic cancer	1.69e-07	2.73e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—EP300—hematologic cancer	1.67e-07	2.69e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—HRAS—hematologic cancer	1.63e-07	2.63e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—VEGFA—hematologic cancer	1.58e-07	2.55e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—STAT3—hematologic cancer	1.57e-07	2.52e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NRAS—hematologic cancer	1.56e-07	2.52e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6—hematologic cancer	1.56e-07	2.52e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—AKT1—hematologic cancer	1.56e-07	2.51e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MAPK3—hematologic cancer	1.5e-07	2.41e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MYC—hematologic cancer	1.46e-07	2.34e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TGFB1—hematologic cancer	1.45e-07	2.34e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—AKT1—hematologic cancer	1.44e-07	2.32e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—KRAS—hematologic cancer	1.35e-07	2.17e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PIK3CA—hematologic cancer	1.24e-07	1.99e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TP53—hematologic cancer	1.2e-07	1.93e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—HRAS—hematologic cancer	1.14e-07	1.84e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6—hematologic cancer	1.09e-07	1.76e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—AKT1—hematologic cancer	1.01e-07	1.63e-06	CbGpPWpGaD
